secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2023-01-26T23:59:59+00:00
Accession:  0001493152-23-002582
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Biostage CEO David Green reduces cash salary to $35,568; receives $264K stock option
--------------------------------------------------------------------------------

- CEO David Green reduced annual base salary from $300,000 to $35,568 (minimum required by law).
- Received nonqualified stock option valued at $264,432 (Black-Scholes) for the salary reduction difference.
- Option vests monthly over 12 months; exercise price equals closing price on grant date (Jan 25, 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223002582/0001493152-23-002582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223002582/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer